Amer Bio Medica Financials
| ABMCDelisted Stock | USD 0.01 0 38.00% |
Amer |
Understanding current and past Amer Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amer Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Amer Bio's assets may result in an increase in income on the income statement.
The data published in Amer Bio's official financial statements usually reflect Amer Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amer Bio Medica. For example, before you start analyzing numbers published by Amer accountants, it's critical to develop an understanding of what Amer Bio's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Amer Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amer Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amer Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amer Bio Medica. Please utilize our Beneish M Score to check the likelihood of Amer Bio's management manipulating its earnings.
Amer Bio Stock Summary
Amer Bio competes with Ace Global, Atlantic American, and Accel Entertainment. American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York. Amer Bio operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 32 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US0246001087 |
| CUSIP | 024600108 |
| Location | New York; U.S.A |
| Business Address | 122 Smith Road, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.abmc.com |
| Phone | 518 758 8158 |
| Currency | USD - US Dollar |
You should never invest in Amer Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Amer Pink Sheet, because this is throwing your money away. Analyzing the key information contained in Amer Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Amer Bio Key Financial Ratios
Generally speaking, Amer Bio's financial ratios allow both analysts and investors to convert raw data from Amer Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Amer Bio over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Amer Bio Medica reports annually and quarterly.Amer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amer Bio's current stock value. Our valuation model uses many indicators to compare Amer Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amer Bio competition to find correlations between indicators driving Amer Bio's intrinsic value. More Info.Amer Bio Medica is number one stock in return on asset category among related companies. It is number one stock in profit margin category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amer Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amer Bio's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amer Bio's earnings, one of the primary drivers of an investment's value.Amer Bio Market Pulse
| Quote | 0.0138 |
| Change(%) | 38.00 |
| Change | 0 |
| Open | 0.01 |
| Low | 0.01 |
| High | 0.0138 |
| Volume | 0 |
| Exchange | PINK |
About Amer Bio Financials
What exactly are Amer Bio Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Amer Bio's income statement, its balance sheet, and the statement of cash flows. Potential Amer Bio investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Amer Bio investors may use each financial statement separately, they are all related. The changes in Amer Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amer Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Amer Bio Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Amer Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Amer has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Amer Bio's financials are consistent with your investment objective using the following steps:- Review Amer Bio's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Amer Bio's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Amer Bio's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Amer Bio's stock is overvalued or undervalued.
Amer Bio April 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amer Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amer Bio Medica. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amer Bio Medica based on widely used predictive technical indicators. In general, we focus on analyzing Amer Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amer Bio's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1146 | |||
| Maximum Drawdown | 150.0 | |||
| Potential Upside | 38.0 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Amer Pink Sheet
If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |